Position in NVS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$18,649
+$319 QoQ
Shares Held
119
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,498
of 1,603 holders
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mosley Wealth Management holds $2,932,900 across 13 Drug Manufacturers - General names. NVS ranks #9 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,003 | $1,270,611 | |
| 2 | ABBV |
AbbVie Inc.
|
1,944 | $489,188 | |
| 3 | AMGN |
Amgen Inc
|
1,327 | $480,533 | |
| 4 | LLY |
ELI LILLY & Co
|
263 | $315,450 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,371 | $194,237 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
814 | $102,840 | |
| 7 | MRK |
Merck & Co., Inc.
|
204 | $26,214 | |
| 8 | GSK |
GSK plc
|
366 | $19,185 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,649 | 119 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $18,330 | 120 | Shares | Sole | 2026-04-27 | |
| 2024-12-31 | $286,869 | 2,948 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $290,770 | 2,528 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $238,257 | 2,238 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $206,325 | 2,133 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $223,749 | 2,216 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||